Back to 
ProShare Advisors LLC
ProShare Advisors LLC
MCRB
Showing 1 of 24 quarters
Position history for ProShare Advisors LLC's holdings in SERES THERAPEUTICS INC
No. ProShare Advisors exited its MCRB (Seres Therapeutics) position in Q3 2024. Its Q2 2024 13F listed 13,175 shares worth $9,536. ProShare Advisors already held MCRB in its Q4 2018 13F, the earliest on record, and held it in 23 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History